132 related articles for article (PubMed ID: 36808247)
1. Pelvis Magnetic Resonance Imaging to Diagnose Familial Partial Lipodystrophy.
Adiyaman SC; Altay C; Kamisli BY; Avci ER; Basara I; Simsir IY; Atik T; Secil M; Oral EA; Akinci B
J Clin Endocrinol Metab; 2023 Jul; 108(8):e512-e520. PubMed ID: 36808247
[TBL] [Abstract][Full Text] [Related]
2. Clinical and imaging features of women with polygenic partial lipodystrophy: a case series.
Loh WJ; Yaligar J; Hooper AJ; Sadananthan SA; Kway Y; Lim SC; Watts GF; Velan SS; Leow MKS; Khoo J
Nutr Diabetes; 2024 Feb; 14(1):3. PubMed ID: 38321009
[TBL] [Abstract][Full Text] [Related]
3. Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety.
Ji H; Weatherall P; Adams-Huet B; Garg A
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1410-3. PubMed ID: 23783098
[TBL] [Abstract][Full Text] [Related]
4. Predicting abdominal adipose tissue among women with familial partial lipodystrophy.
Joy T; Kennedy BA; Al-Attar S; Rutt BK; Hegele RA
Metabolism; 2009 Jun; 58(6):828-34. PubMed ID: 19375764
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety).
Garg A; Peshock RM; Fleckenstein JL
J Clin Endocrinol Metab; 1999 Jan; 84(1):170-4. PubMed ID: 9920078
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging.
Al-Attar SA; Pollex RL; Robinson JF; Miskie BA; Walcarius R; Little CH; Rutt BK; Hegele RA
BMC Med Imaging; 2007 Mar; 7():3. PubMed ID: 17352814
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study.
Foss-Freitas MC; Akinci B; Neidert A; Bartlett VJ; Hurh E; Karwatowska-Prokopczuk E; Oral EA
Lipids Health Dis; 2021 Dec; 20(1):174. PubMed ID: 34865644
[TBL] [Abstract][Full Text] [Related]
10. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.
Guillín-Amarelle C; Sánchez-Iglesias S; Castro-Pais A; Rodriguez-Cañete L; Ordóñez-Mayán L; Pazos M; González-Méndez B; Rodríguez-García S; Casanueva FF; Fernández-Marmiesse A; Araújo-Vilar D
Endocrine; 2016 Nov; 54(2):411-421. PubMed ID: 27473102
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic.
Iwanishi M; Ito-Kobayashi J; Washiyama M; Kusakabe T; Ebihara K
Intern Med; 2018 Aug; 57(16):2301-2313. PubMed ID: 29607946
[TBL] [Abstract][Full Text] [Related]
12. Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.
Krawiec P; Mełges B; Pac-Kożuchowska E; Mroczkowska-Juchkiewicz A; Czerska K
BMC Pediatr; 2016 Mar; 16():38. PubMed ID: 26976018
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study.
Guidorizzi NR; Valerio CM; Viola LF; Veras VR; Fernandes VO; Lima GEDCP; Flor AC; Araújo JS; Gonçalves Muniz RB; Moreira RO; De Paula FJA; Zajdenverg L; Dantas JR; Godoy-Matos AF; Montenegro Júnior RM; Foss-Freitas MC
Front Endocrinol (Lausanne); 2024; 15():1359211. PubMed ID: 38887266
[TBL] [Abstract][Full Text] [Related]
14. The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity.
Koo E; Foss-Freitas MC; Meral R; Ozer M; Eldin AJ; Akinci B; Miller N; Rothberg AE; Oral EA
Obesity (Silver Spring); 2021 Feb; 29(2):274-278. PubMed ID: 33491315
[TBL] [Abstract][Full Text] [Related]
15. [Dunnigan-type familial partial lipodystrophy: attention to precocious diagnosis].
Leão LM; Alencar RC; Rodrigues Gda C; Bouzas I; Gallo P; Rossini A
Rev Bras Ginecol Obstet; 2011 Feb; 33(2):99-103. PubMed ID: 21779653
[TBL] [Abstract][Full Text] [Related]
16. Visualisation pattern of fat distribution of a rare disorder: familial partial lipodystrophy (FPLD).
Carvalho V; Capett MS; Ulhôa RJS
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732355
[No Abstract] [Full Text] [Related]
17. Muscle and nerve pathology in Dunnigan familial partial lipodystrophy.
Spuler S; Kalbhenn T; Zabojszcza J; van Landeghem FK; Ludtke A; Wenzel K; Koehnlein M; Schuelke M; Lüdemann L; Schmidt HH
Neurology; 2007 Feb; 68(9):677-83. PubMed ID: 17325275
[TBL] [Abstract][Full Text] [Related]
18. A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.
Imachi H; Murao K; Ohtsuka S; Fujiwara M; Muraoka T; Hosokawa H; Ishida T
Endocrine; 2009 Feb; 35(1):18-21. PubMed ID: 19011997
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.
Park JY; Javor ED; Cochran EK; DePaoli AM; Gorden P
Metabolism; 2007 Apr; 56(4):508-16. PubMed ID: 17379009
[TBL] [Abstract][Full Text] [Related]
20. "Fat Shadows" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers.
Meral R; Ryan BJ; Malandrino N; Jalal A; Neidert AH; Muniyappa R; Akıncı B; Horowitz JF; Brown RJ; Oral EA
Diabetes Care; 2018 Oct; 41(10):2255-2258. PubMed ID: 30237235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
